Replies to post #201450 on Biotech Values

[DewDiligence]

Another CMC “gotcha”—Intarcia receives CRL for Exenatide implant:

http://www.prnewswire.com/news-releases/intarcia-provides-corporate-update-300527104.html

The Company received clear and constructive guidance from the Agency regarding manufacturing aspects of the CRL and is on a clear path to move forward.

Emphasis added.

Intarcia has been a high-profile private biotech company, having raised $225M in 2015 (#msg-113238024).